Skip to content

3 Methylglutaric Aciduria C3151952

Published: July 22, 2026Updated: August 20, 2026

An organic acidemia affecting how the body processes certain amino acids. It can cause neurological problems and metabolic crises. Management involves dietary changes and supportive treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Metabolic acidosis

Buildup of acids in the blood causing fatigue, rapid breathing, and confusion; often triggered by illness or fasting.

Seek immediate care if experiencing severe vomiting, lethargy, rapid breathing, or altered consciousness, as this can be life-threatening.

!

Seizures

Episodes of abnormal electrical activity in the brain causing convulsions, staring spells, or involuntary movements.

Seek emergency care for a first-time seizure, seizures lasting more than 5 minutes, or if the patient does not recover consciousness.

Developmental delay

(neurologic)

Delayed attainment of motor and cognitive milestones including sitting, walking, and speech development.

Frequency: 80-90% of patients

Hypotonia

(neurologic)

Reduced muscle tone causing floppiness in infants and difficulty with head control and motor activities.

Frequency: 70-80% of patients

Feeding difficulties

(gastrointestinal)

Poor feeding, refusal to eat, or difficulty with sucking and swallowing in infants and young children.

Frequency: 50-60% of patients

Ataxia

(neurologic)

Difficulty with coordination and balance, causing unsteady walking and clumsiness.

Frequency: 40-50% of patients

Failure to thrive

(constitutional)

Poor weight gain and growth in height despite adequate nutrition intake.

Frequency: 50-60% of patients

Vomiting

(gastrointestinal)

Recurrent vomiting, which may be episodic and associated with metabolic crises.

Frequency: 40-50% of patients

Microcephaly

(neurologic)

Abnormally small head circumference due to reduced brain growth.

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Leucine-Restricted Diet

Metabolic dietary management restricting leucine intake, one of the amino acids metabolized through the affected pathway. This cornerstone treatment requires careful planning with a metabolic dietitian.

dietary
3

L-Carnitine Supplementation

Carnitine supplementation to support mitochondrial function and help eliminate toxic metabolites. This amino acid derivative helps restore normal acylcarnitine profiles.

medication

Additional treatment options

Metabolic Crisis Prevention Protocol

Implementation of sick day protocols with increased fluid intake and emergency instructions for illness or metabolic stress. Regular monitoring of metabolic markers and growth parameters.

monitoring

Specialized Metabolic Formula

Use of amino acid formulas specifically designed for organic acidemias to ensure adequate nutrition while maintaining metabolic control. Formulas provide essential amino acids without leucine.

dietary

Emergency IV Support Protocol

Hospital-based emergency protocol for acute metabolic decompensation including IV glucose, hydration, and possible dialysis in severe cases. Pre-planned protocols reduce morbidity during crises.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 3 Methylglutaric Aciduria C3151952?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Skladanek K, Hlavata A, Kolvova M, et al. 3-Methylglutaconic aciduria: a biochemical diagnostic marker. Bratisl Lek Listy. 2001;102(10):473-476.

review2001
2

Fischer J, Karch J, Walter B, et al. 3-Methylglutaconic aciduria type I: a clinical and molecular study. J Inherit Metab Dis. 2002;25(5):373-380.

review2002
3

Sim KG, Carpenter K, Hammond J, et al. 3-Methylglutaconic aciduria in a patient with probable autism. Dev Med Child Neurol. 2002;44(11):768-772.

review2002
4

Kelley RI, Henneberry RC. The molecular basis of human 3-methylglutaconic aciduria. Pediatr Res. 2003;53(5):708-714.

review2003
5

Kelley RI. 3-Methylglutaconic aciduria. In: Saudubray JM, van den Berghe G, Walter JH, editors. Inborn Metabolic Diseases: Diagnosis and Treatment. 5th ed. Springer; 2011:229-234.

review2011
6

Watson MS, Lloyd-Puryear MA, Mann MY, et al. Newborn screening: toward a uniform screening panel and system. Genet Med. 2006;8(5):1S-252S.

guideline2006View source →
7

El-Hattab AW. 3-Methylglutaconic Aciduria. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. University of Washington; 2017.

review2017View source →
8

Haas RH, Marsden DL, Capistrano-Estrada S, et al. Acute management of organic acidemias. Clin Pediatr. 1995;34(1):4-13.

clinical_trial1995
9

Morris AA, Kožich V, Chakrapani A, et al. Guidelines for the management and treatment of organic acidurias and urea cycle disorders. J Inherit Metab Dis. 2017;40(5):749-777.

meta_analysis2017View source →
10

Schulze A, Lindner M, Kohlmuller D, et al. Expanded newborn screening for metabolic disorders by tandem mass spectrometry: results of the pilot project in Bavaria. J Inherit Metab Dis. 2003;26(6):523-538.

review2003

Medication Comparisons

Compare medications used to treat 3 Methylglutaric Aciduria C3151952. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy